Aratana Therapeutics Inc (NASDAQ:PETX)

13.34
Data as of Nov 25
 -0.13 / -0.97%
Today’s Change
9.20
Today|||52-Week Range
25.50
-30.16%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$467.5M

Company Description

Aratana Therapeutics, Inc. is a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets, or pet therapeutics. It delivers innovative prescription medicines that address significant medical needs for cats and dogs (companion animals). The company licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. Aratana Therapeutics was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Kansas City, KS.

Contact Information

Aratana Therapeutics, Inc.
1901 Olathe Boulevard
Kansas City Kansas 66103
P:(913) 951-2132
Investor Relations:

Employees

Shareholders

Other institutional39.18%
Mutual fund holders35.95%
Individual stakeholders27.34%

Top Executives

Steven St. PeterPresident, Chief Executive Officer & Director
Craig A. ToomanChief Financial Officer
Linda RhodesDirector & Chief Scientific Officer
Erwin BlomsmaVice President
Michele A. GallucciVice President-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.